Neuromuscular Disorders
Volume 11, Issue 4 , Pages 350-359, May 2001

Massive muscle cell degeneration in the early stage of merosin-deficient congenital muscular dystrophy

  • Yukiko K Hayashi

      Affiliations

    • Department of Neuromuscular Research, National Institute of Neuroscience, NCNP, Ogawa-Higashi, Kodaira, Tokyo, Japan
  • ,
  • Zivana Tezak

      Affiliations

    • Children's National Medical Center, Children's Research Institute, Center for Genetic Medicine, Washington DC, USA
  • ,
  • Takashi Momoi

      Affiliations

    • Department of Inherited Metabolic Disease, National Institute of Neuroscience, NCNP, Ogawa-Higashi, Kodaira, Tokyo, Japan
  • ,
  • Ikuya Nonaka

      Affiliations

    • National Center Hospital for Mental, Nervous and Muscular Disorders, NCNP, Ogawa-Higashi, Kodaira, Tokyo, Japan
  • ,
  • Carlos A Garcia

      Affiliations

    • Department of Neurology, Tulane University Medical Center, New Orleans, LA, USA
  • ,
  • Eric P Hoffman

      Affiliations

    • Children's National Medical Center, Children's Research Institute, Center for Genetic Medicine, Washington DC, USA
  • ,
  • Kiichi Arahata

      Affiliations

    • Department of Neuromuscular Research, National Institute of Neuroscience, NCNP, Ogawa-Higashi, Kodaira, Tokyo, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-423-41-2711; fax: +81-423-46-1742

Received 28 March 2000; received in revised form 2 August 2000; accepted 23 September 2000.

Abstract 

Primary merosin-deficient congenital muscular dystrophy (CMD) is a severe form of congenital muscular disorder which is caused by mutations in the laminin α2 chain gene (LAMA2). The disease is characterized by marked dystrophic changes in skeletal muscles during early infancy, while little is known about the pathological process of the muscle fiber degeneration. Here, we report the immunohistochemical analysis of skeletal muscle in ten patients with primary merosin-deficient CMD using a panel of molecular markers for skeletal muscle proteins, cellular necrosis, and apoptosis. In the youngest patient (a 52 day old baby), prominent massive muscle cell degeneration occurred in association with the deposition of the C5-9 complement membrane attack complex (MAC). Most of the MAC-positive muscle fibers showed a severely deranged immunoreaction to dystrophin, dystroglycans, and other sarcolemmal proteins. In addition, we found scattered positive signals for apoptosis. Similar but milder changes were also observed in six other patients younger than 1 year. In the patients older than 3 years, muscle fibers positive for MAC and apoptotic signals were barely detectable. These findings imply that massive muscle fiber degeneration occurs in the very early stage of merosin-deficient CMD and may contribute to the severe dystrophic changes in muscle from early infancy.

Keywords:  Congenital muscular dystrophy, Necrosis, Apoptosis, Membrane attack complex, Caspase, Laminin, Merosin

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0960-8966(00)00203-0

Neuromuscular Disorders
Volume 11, Issue 4 , Pages 350-359, May 2001